FindTrial
Sign In

ââ?¬Å?COMPARISON OF BUPIVACAINE WITH FENTANYL AND ROPIVACAINE WITH FENTANYL IN UPPER LIMB SURGERY UNDER SUPRACLAVICULAR BRACHIAL BLOCKââ?¬?

ââ?¬Å?A COMPARATIVE STUDY OF BUPIVACAINE WITH FENTANYL AND ROPIVACAINE WITH FENTANYL IN UPPER LIMB SURGERY UNDER SUPRACLAVICULAR BRACHIAL BLOCKââ?¬?

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039745
Enrollment
60
Registered
2022-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M849- Disorder of continuity of bone, unspecified Health Condition 2: V863- Unspecified occupant of special all-terrain or other off-road motor vehicle injured in traffic accident

Interventions

Intervention1: Evaluation of bupivacaine with fentanyl: Evaluation of onset of sensory, motor blockade and duration of analgesia, 30 ml of bupivacaine and 1mcg/kg of fentanyl Intervention2: Evaluation

Sponsors

Dr AKSHAY R M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 1.ASA grade I or II of either sex 2. Ages between 18 to 60 years of either sex 3. Patients undergoing elective upper limb surgeries.

Exclusion criteria

Exclusion criteria: 1 Parents/Guardian refusal or not giving consent. 2 Patients with Neurological disease. 3 Local skin infections or disease. 4 Patients with bleeding diathesis. 5 History of drug allergy to bupivacaine, Ropivacaine and Fentanyl Coagulopathy. � Sever liver or kidney diseases.

Design outcomes

Primary

MeasureTime frame
INJECTION BUPIVACAINE WITH FENTANYL IS MORE HEMODYNAMICALLY STABLE AND HAS GOOD ANALGESIATimepoint: 4weeks—

Secondary

MeasureTime frame
INJECTION BUPIVACAINE WITH FENTANYL IS MORE HEMODYNAMICALLY STABLE AND HAS GOOD ANALGESIA, WITH BETTER SENSORY AND MOTOR BLOCKADETimepoint: 8 weeks—

Countries

India

Contacts

Public ContactDR GAJENDRA SINGH

MAHADEVAPPA RAMPURE MEDICAL COLLEGE

gajendra.glb@gmail.com9886252233

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026